Development of non-invasive diagnostic test based on fetal DNA isolated from maternal blood (NATERA-study)

Development of non-invasive diagnostic test based on fetal DNA isolated from maternal blood (NATERA-study) - NATERA-studie

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37477

Enrollment

300

Registered

2013-02-01

Start date

2013-10-21

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chromosomal aberriations genetic defect

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Maternal blood samples: > 18 years of age, informed consent given diagnosis of abnormal or genetic disorder diagnosed by either amniocentesis or chorionic villus sampling before (spontanious) abortion;Blood, buccal or saliva collection biological father: >18 years, informed consent

Exclusion criteria

Exclusion criteria: Maternal blood samples: After spontanious abortion or dilation and curettage

Design outcomes

Primary

Measure	Time frame
The development and perfection of a noninvasive test in maternal blood detecting chromosomal aberrations.	—

Countries

Netherlands

Outcome results